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Introduction
Sickle cell disease (SCD) is a chronic condition with 
extensive morbidity that predominately affects minority 
children and increases the risk of stroke, a leading cause 
of childhood death and disability.1-3 Without interven-
tion, approximately 11% of children with SCD would 
have a stroke by 20 years of age; however, many of these 
strokes are now preventable.1,4-6 Transcranial Doppler 
(TCD) screening detects high blood flow velocities in 
cerebral vessels which indicate an increased stroke risk 
and signal the need to initiate chronic blood transfusions 
as a key stroke prevention strategy.4,7,8 The Stroke 
Prevention Trial in Sickle Cell Anemia, published in 
1998, showed once transfusions are initiated, stroke 
incidence is sharply reduced by up to 90% relative to 
standard medical care.4
Given its importance as a stroke prevention strategy, 
numerous national organizations have released guide-
lines recommending TCD screening among children 
with SCD. However, these guidelines differ substantially 
in key areas, with the National Heart Lung and Blood 
Institute (NHLBI) providing the most specific guide-
lines.9-11 Adherence to clinical practice guidelines such 
as these has been demonstrated to be beneficial in 
improving health outcomes for patients across many spe-
cialties.12-16 Despite these findings, physician adherence 
to guidelines remains low, particularly in the clinical spe-
cialty of pediatrics.17-21 Ambiguities and differences in 
these guidelines may lead to variability in physicians’ 
recommendation of TCD screening among children with 
SCD, as suggested by the low rates of screening observed 
in numerous settings.22-25
Importantly, children with SCD have significantly 
higher healthcare utilization than children without SCD, 
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Objective. We explored factors that may influence physician adherence to transcranial Doppler (TCD) screening 
guidelines among children with sickle cell disease. Methods. Pediatric hematologists, neurologists, and primary care 
physicians (n = 706) responded to a mailed survey in May 2012 exploring factors hypothesized to influence physician 
adherence to TCD screening guidelines: physician (internal) barriers and physician-perceived external barriers. 
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Proportion of correct answers on knowledge questions was low (13%-35%). Distance to a vascular laboratory and 
low patient adherence were external barriers to receipt of TCD screening. Conclusions. Additional research regarding 
physicians’ lack of self-efficacy and knowledge of recommendations could help clarify their role in recommendation 
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indicating that opportunities for recommending TCD 
screening exist.2 Because the degree of physician adher-
ence to TCD screening guidelines may influence screen-
ing rates, our objective was to explore factors that may 
be related to adherence such as physicians’ awareness, 
attitudes, and knowledge of TCD screening guidelines 
for children with SCD. We also assessed physician-per-
ceived external barriers to administration of TCD 
screening in children with SCD among primary and spe-
cialty care physicians.
Methods
Study Population
Pediatric hematologists, pediatric neurologists, and pri-
mary care physicians (PCPs) were chosen as the study 
population as these physicians would be most likely to 
treat children with SCD. Pediatric hematologists and 
pediatric neurologists (n = 250 each because of cost 
limitations) were randomly sampled across the United 
States (because of insufficient numbers of these special-
ties in the state of Michigan) from the American Medical 
Association (AMA) Physician Masterfile. The AMA 
Masterfile is a continuously updated list of all physi-
cians in the United States which includes both members 
and nonmembers of the AMA. PCPs were identified as 
physicians with a certification in general pediatrics, 
family medicine, or adolescent medicine treating chil-
dren with SCD. To increase the likelihood of the physi-
cian treating a child with SCD, PCPs were included if 
they had 1 or more Michigan Medicaid claims reporting 
an International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9 CM) diagnosis 
code for SCD from 2008-2012 (n = 206). Consistent 
with other studies, we included diagnosis codes for 
sickle cell anemia (282.60, 282.61, 282.62), Hb SC 
(282.63, 282.64), Hb SD (282.68, 282.69), and Hb S  β 
thalassemia (282.41 and 282.420).26-28 Medicaid claims 
for states other than Michigan were not available to 
identify physicians treating children with SCD in these 
states.
Survey Development, Content, and 
Administration
The physician survey was developed by the lead author 
(SLR) and revised based on input from the research 
team. Elements of the survey were chosen based on the 
framework presented by Cabana et al,29 which organized 
physician barriers into 7 major categories. Our survey 
content was developed based on factors hypothesized to 
influence physician adherence to TCD guidelines 
specifically and included the following: physician 
(internal) barriers (awareness, attitudes, and knowledge 
of guidelines), physician-perceived external barriers, 
and physician and practice characteristics (Figure 1, 
adapted from Cabana et al29).
Awareness of TCD screening guidelines was assessed 
through questions about familiarity and accessibility of 
national guidelines for TCD screening. Attitudes regard-
ing TCD screening for children with SCD were assessed 
through agreement with a series of statements regarding 
outcome expectancy (SCD stroke risk, predictive value 
of TCD results, chronic exchange transfusion), percep-
tion of guidelines (strength of evidence, conflicting 
guidelines), and self-efficacy (comfort caring for chil-
dren with SCD and with TCD screening, ability to 
reduce stroke risk). Knowledge of TCD screening 
guidelines for children with SCD was assessed through 
a series of multiple choice and open-ended questions 
regarding types of SCD to screen, ages to initiate and 
terminate screening, and actions to take based on TCD 
screening results. Correct responses to knowledge ques-
tions were based on agreement with NHLBI9 guidelines 
for treatment of children with SCD, as these guidelines 
are the most specific regarding TCD screening among 
children with SCD and are often used among clinics 
developing TCD screening programs.30 Physician-
perceived external barriers to TCD screening focused on 
agreement with statements in 3 main areas: access/envi-
ronmental barriers, patient barriers, and administrative 
barriers. Level of agreement with each attitude and 
external barrier statement was assessed using a 5-point 
Likert-type scale: strongly disagree (1) to strongly agree 
(5). Physician and practice characteristics assessed were 
physician’s sex, race, ethnicity, age, years of practice, 
specialty, hours of general continuing medical educa-
tion, patient characteristics, and practice affiliation. The 
complete survey is included in online appendix A (http://
clp.sagepub.com/content/by/supple-mental-data).
The survey was piloted for content and clarity with at 
least 1 physician from each specialty and questions were 
modified based on feedback. The survey was adminis-
tered via priority mail in May 2012 with a $2 incentive 
included. A follow-up mailing was conducted among 
nonrespondents without an incentive in June 2012. 
Survey collection was closed on December 31, 2012.
Eligibility
Physicians were eligible to complete the survey if the 
survey was deliverable and they indicated on the survey 
that she or he currently provided care for children with 
SCD. All eligible physicians were asked to answer ques-
tions regarding attitudes and perspectives on TCD 
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screening and physician and practice characteristics. 
Physicians who believed patients with SCD should 
receive TCD screening (92%) were then asked to answer 
questions regarding knowledge of specific guidelines 
and physician perceived external barriers, as these phy-
sicians would be the most appropriate recipients of 
interventions aimed at increasing adherence to screen-
ing guidelines.
Statistical Analysis
Means and standard deviations (SD) or frequencies and 
percentages were calculated for physician and practice 
demographics. Responses regarding attitudes toward 
guidelines regarding TCD screening and external barri-
ers were collapsed into categories of agree (strongly 
agree or agree) or disagree (strongly disagree, disagree, 
neutral) and compared across specialties using chi-
square tests. Knowledge of specific NHLBI guidelines 
was calculated as the proportion of questions answered 
correctly (6 knowledge questions were included in the 
survey) and compared across specialties using Fisher’s 
exact tests because of small sample size for some cells. 
Frequencies of responses for all other questions were 
calculated overall and by specialty.
The study was approved by the institutional review 
board of the University of Michigan (#HUM000525-47).
Results
A total of 706 physicians were sent surveys; 65 were 
undeliverable, 8 physicians had retired, and 276 were 
returned by the respondent (44% response rate among 
deliverable surveys). Among the 276 respondents, 141 
(51%) physicians currently treated children with SCD 
(28% PCPs, 21% pediatric neurologists, and 51% pediat-
ric hematologists). Among these physicians, 61% were 
male, 73% were white, 18% Asian or Pacific Islander, 4% 
black, and 4% other, and 4% were of Hispanic origin. The 
average respondent was 52 years old (SD 11 years) and 
had been practicing for 19 years (SD 12 years). The 
respondents varied by other practice and physician 
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characteristics (Table 1). Overall, 127 (92%) out of the 
141 respondents who treat children with SCD believed 
that children with SCD should receive TCD screening 
(82% PCPs, 90% pediatric neurologists, 99% pediatric 
hematologists) and of these, 97 (72%) currently recom-
mend screening to their patients (34% PCPs, 64% pediat-
ric neurologists, 94% pediatric hematologists). Reasons 
for not recommending TCD screening included referring 
the patient to a hematologist (n = 17), another doctor (n = 
2), or a sickle cell center (n = 4) for screening, or lack of 
familiarity with guidelines (n = 6).
Internal Barriers: Awareness
Sixty-seven percent of eligible respondents indicated 
they were extremely, very, or moderately familiar with 
national guidelines regarding TCD screening among 
children with SCD (30% of PCPs, 61% of pediatric neu-
rologists and 90% of pediatric hematologists, P < .0001), 
and 33% indicated they were slightly or not at all famil-
iar. If more information was needed regarding TCD 
screening, 66% of respondents indicated they would 
refer to the American Academy of Pediatrics (AAP), 
44% the NHLBI, 35% Up To Date Inc (an online, evi-
dence-based clinical support resource), 26% the 
American Academy of Neurology, and 5% the American 
Heart Association. Other sources of information 
included the American Society of Hematology (n = 5), 
other doctors or centers (n = 5) or research papers, text-
books, other Websites or guidelines (n = 8).
Internal Barriers: Attitudes
Attitudes regarding TCD screening among children 
with SCD differed by statement and among specialties 
(Table 2). Most physicians felt comfortable caring for 
children with SCD and believed these children have a 
high risk of stroke. Additionally, most had positive per-
ceptions of guidelines with few indicating that guide-
lines were based on questionable evidence or that 
conflicting guidelines existed. The majority (64%) of 
PCPs did not feel well informed regarding TCD guide-
lines, whereas only 28% of pediatric neurologists and 
7% of hematologists did not feel well informed (P < 
.0001). Self-efficacy questions revealed similar spe-
cialty patterns, with PCPs feeling most uncomfortable 
discussing risks and benefits of TCD screening with 
patients and families and their ability to reduce stroke 
risk in patients with SCD. The vast majority of physi-
cians would recommend chronic exchange transfusion 
based on abnormal TCD results (95% PCPs, 99% pedi-
atric neurologists, and 93% pediatric hematologists).
Internal Barriers: Knowledge
Among physicians who believe children with SCD 
should receive TCD screening (n = 127), the proportion 
of knowledge questions answered correctly based on 
Table 1. Characteristics of Physicians Treating Children 
With Sickle Cell Disease Responding to Survey (n = 141).
n (%)
Sex
 Male 84 (60)
 Female 53 (38)
Race
 White 99 (70)
 Black 6 (4)
 Asian/Pacific Islander 24 (17)
 Other 6 (4)
Ethnicity
 Non-Hispanic 126 (89)
 Hispanic 5 (4)
 Age in years, mean (SD) 52 (11)
 Years of practice, mean (SD) 19 (12)
Specialty
 Pediatric hematology 72 (51)
 Pediatrics/family medicine 
(PCPs)
40 (28)
 Pediatric neurology 29 (21)
Hours of CME per month
 <1 3 (2)
 1-5 81 (57)
 >5 55 (39)
Pediatric patients with sickle cell disease (%)
 <5 78 (55)
 5-10 24 (17)
 11-20 14 (10)
 >20 22 (16)
Pediatric patients covered by Medicaid (%)
 <5 7 (5)
 5-24 19 (13)
 25-49 41 (29)
 >50 65 (46)
Primary practice ownership
 Private office 21 (15)
 University/hospital/medical 
center
91 (65)
 Practice network 10 (7)
 Sickle cell center 13 (9)
 Combination 2 (1)
Pediatric patients per year
 1-500 34 (24)
 501-1500 53 (38)
 1501-3000 37 (26)
 >3000 14 (10)
Abbreviations: PCP, primary care physicians; CME, continuing 
medical education.
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NHLBI guidelines was low. Overall, the question with 
the highest percentage of correct responses was the age 
to begin TCD screening (35% correct), and the lowest 
was actions to take on an abnormal TCD screening result 
(13% correct). Percentage of correct responses differed 
among specialty, with PCPs and pediatric neurologists 
consistently scoring lower than pediatric hematologists 
(Table 3).
External Barriers
Two physician-perceived external barriers were reported 
by the majority of physicians to hinder receipt of TCD 
screening; distance to a vascular laboratory (51%) and 
low patient adherence to TCD appointments (56%). In 
general, PCPs selected more barriers than pediatric neu-
rologists or hematologists. Physician-perceived external 
Table 2. Agreement With Physician Perceptions and Attitudes Regarding Transcranial Doppler Screening (n = 141).
n (%)
Statement Overalla
Primary Care 
Physiciansa n = 40
Pediatric Neurologya 
n = 29
Pediatric 
Hematologya n = 72 P Valueb
I feel comfortable caring for 
children with sickle cell disease.
119 (86) 28 (71) 20 (71) 71 (99) <.001
Children with sickle cell disease 
have a high risk of stroke.
130 (93) 34 (87) 29 (100) 67 (93) .13
I do not feel well informed 
regarding transcranial Doppler 
ultrasonography guidelines for 
children with sickle cell disease.
38 (27) 25 (64) 8 (28) 5 (7) <.001
I do not feel comfortable discussing 
risks and benefits of transcranial 
Doppler ultrasonography with my 
patients and their families.
36 (26) 21 (54) 7 (24) 8 (11) <.001
Guidelines for transcranial Doppler 
ultrasonography for children with 
sickle cell disease are based on 
questionable evidence.
7 (5) 5 (13) 0 (0) 2 (3) .02
There are conflicting guidelines 
regarding transcranial Doppler 
ultrasonography for children with 
sickle cell disease.
15 (11) 7 (18) 3 (10) 5 (7) .18
Transcranial Doppler 
ultrasonography results predict 
stroke risk.
96 (69) 14 (37) 17 (59) 65 (90) <.001
I am confident in my ability to 
reduce the risk of stroke in my 
patients with sickle cell disease.
68 (49) 6 (16) 12 (41) 50 (69) <.001
I will not recommend chronic 
exchange transfusion regardless 
of transcranial Doppler 
ultrasonography results.
5 (4) 2 (5) 2 (7) 1 (1) .34
Chronic exchange transfusion is 
effective at reducing stroke risk 
among children with sickle cell 
disease.
108 (78) 18 (46) 24 (83) 66 (93) <.001
Hydroxyurea is effective at 
reducing stroke risk among 
children with sickle cell disease.
54 (39) 17 (44) 10 (36) 27 (39) .79
I am comfortable discussing the 
risks and benefits of chronic 
exchange transfusion with my 
patients and their families.
89 (64) 13 (33) 10 (34) 66 (93) <.001
aUp to 4 physician responses missing (varies by statement).
bP value comparing percentage agreement across physician specialties.
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barriers differed across specialties for the majority of 
barriers (Table 4).
Discussion
Abnormal TCD results in children with SCD are associ-
ated with a high risk of stroke and should prompt stroke 
prevention efforts in the form of chronic blood transfu-
sions. Although the effectiveness of blood transfusion 
for stroke prevention has been known since the late 
1990s, rates of TCD screening among children with 
SCD have remained low.4,23 Physicians’ awareness, atti-
tudes, and knowledge of TCD guidelines for children 
with SCD may influence physician recommendation of 
TCD screening; however, no study has investigated 
these internal factors. In our study, the majority of physi-
cians believed children with SCD have a high risk of 
stroke and should receive TCD screening, but familiar-
ity with guidelines, self-efficacy, and knowledge of 
NHLBI-specific guidelines were low, particularly 
among PCPs, and differed considerably by specialty. 
Additionally, we identified distance from child’s home 
to a vascular laboratory and patient adherence to 
appointments as physician-perceived external barriers.
Among attitudes regarding TCD guidelines, self-effi-
cacy (comfort discussing risks and benefits of TCD 
screening and blood transfusions, ability to reduce 
stroke risk among patients) and outcome expectancy 
(TCD predicts stroke risk, blood transfusions reduce 
stroke risk) showed the largest specialty differences, 
with PCPs and pediatric neurologists consistently rat-
ing themselves lower in these categories than pediatric 
hematologists. However, the overall proportion of phy-
sicians with high self-efficacy and outcome expectancy 
was still low, indicating a need for improvement in 
these areas across all specialties. Interventions focusing 
on improving self-efficacy among physicians, such as 
educational toolkits, formal clinical training, and 
increased availability of educational resources have been 
successful in increasing confidence and knowledge 
among physicians across the board.31-33 As most physi-
cians felt comfortable caring for children with SCD, these 
educational interventions might be best focused on 
increasing physician knowledge of the risks and benefits 
of TCD screening and blood transfusions, as these were 
areas in need of improvement among all physicians. 
These educational targets are in line with the SCD-related 
research agenda released by the NHLBI which identified 
clear, evidence based guidelines for physicians as a prior-
ity,34 and numerous quality improvement collaborations 
focused on improving care and outcomes among children 
with SCD.35 Influencing attitudes through enhancement 
of knowledge and confidence may positively affect adher-
ence to guidelines, especially among PCPs and pediatric 
neurologists, although this requires further study.
With regard to knowledge, questions about next steps 
for abnormal TCD results were answered incorrectly 
with the highest frequency. This indicates the need for 
increased physician education regarding actions to take 
based on TCD screening results since these actions are 
the basis for stroke prevention efforts. Also, questions 
about ages to begin and end screening were answered 
incorrectly by the majority of respondents which could 
potentially lead to differential TCD screening rates by 
age. As hematologists’ knowledge and familiarity 
regarding guidelines was higher than neurologists and 
PCPs, increased referral by other physicians to hema-
tologists could be an important driver of increased TCD 
screening. This may be especially true considering only 
one third of PCPs reported recommended screening to 
their patients and the majority of PCPs who did not rec-
ommend screening referred the patient to a hematologist 
Table 3. The Proportion of Knowledge Questions Answered Correctly Based on National Heart Lung and Blood Institute 
Guidelines (n = 127).
Knowledge Topic
Overall 
(%)
Primary Care 
Physicians n = 31 (%)
Pediatric Neurologist 
n = 26 (%)
Pediatric Hematologist 
n = 70 (%) P Valuea
Age to begin TCD Screening 35 16 12 53 <.0001
Age to end TCD screening 20 3 8 33 .0003
Sickle cell subtypes to screen 31 13 0 50 <.0001
Actions to take with normal 
TCD result
31 10 15 46 .0002
Actions to take with conditional 
TCD result
22 10 12 33 .01
Actions to take with abnormal 
TCD result
13 3 4 20 .02
Abbreviation: TCD, transcranial Doppler ultrasonography.
aP value comparing percentage correct across physician specialties.
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for TCD screening. Since treatment guidelines for chil-
dren with SCD recommend frequent contact with 
hematologists, patient adherence to these specialist 
appointments may be integral to increasing TCD screen-
ing rates. However, it may also be important to continue 
to increase knowledge of TCD guidelines among PCPs, 
as not all children will see a hematologist each year. 
Although hematologists did answer the knowledge 
questions correctly with the highest frequency, the pro-
portion of correct answers among hematologists was 
low. There is still substantial room for improvement in 
their knowledge of specific guidelines, particularly if 
they are perceived as the primary initiator of TCD 
screening among children with SCD.
Table 4. Agreement With Physician-Perceived Barriers for Receipt of Transcranial Doppler Screening (n = 127).
n (%) Agree With Statement
Statement
Overall 
Agreementa
Primary Care 
Physiciansa n = 31
Pediatric Neurologya 
n = 26
Pediatric 
Hematologya n = 70 P Valueb
Distance from patients’ homes to 
vascular laboratories is a barrier 
to receipt of transcranial Doppler 
ultrasonography.
64 (51) 19 (63) 7 (27) 38 (54) .02
Authorization from private 
insurance carriers is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
38 (30) 15 (50) 10 (38) 13 (19) .004
Authorization from Medicaid is a 
barrier to receipt of transcranial 
Doppler ultrasonography.
26 (21) 11 (37) 7 (27) 8 (11) .01
Lack of time/resources to describe 
risks and benefits to my patients 
and families is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
25 (20) 16 (53) 4 (15) 5 (7) <.001
Parental refusal is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
32 (26) 12 (40) 3 (12) 17 (24) .06
Reimbursement from private 
insurance carriers is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
28 (22) 15 (50) 8 (31) 5 (7) <.001
Reimbursement from Medicaid is a 
barrier to receipt of transcranial 
Doppler ultrasonography.
22 (18) 10 (33) 8 (31) 4 (6) <.001
Lack of appropriate staff to 
interpret results is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
26 (21) 7 (23) 7 (27) 12 (17) .53
Low patient adherence to 
appointments is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
70 (56) 18 (60) 6 (24) 46 (66) .001
Lack of insurance is a barrier to 
receipt of transcranial Doppler 
ultrasonography.
40 (32) 15 (50) 8 (31) 17 (24) .04
Lack of parental belief that their child 
is at an increased risk for stroke is 
a barrier to receipt of transcranial 
Doppler ultrasonography.
51 (41) 14 (47) 10 (38) 27 (39) .73
aUp to 3 physician responses missing (varies by statement).
bP value comparing percentage correct across physician specialties.
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Our survey showed the AAP to be the most common 
source referenced for information regarding TCD 
screening. These guidelines are the most ambiguous 
given their recommendation that TCD screening should 
be discussed, if available.11 While both the NHLBI9 and 
American Heart Association10 strongly recommend 
TCD screening, their respective guidelines differ with 
regard to recommended ages for screening, frequency of 
screening and actions to be taken based on screening 
results. The AAP’s more ambiguous recommendation 
has provoked controversy among pediatricians who feel 
stronger guidelines are warranted.36 We used the NHLBI 
guidelines as the standard for knowledge which may 
have influenced our results with respect to the propor-
tion of correct answers.24,30
Few studies exist regarding physician-perceived 
external factors that may influence TCD screening rates. 
We found that physicians perceive lack of adherence to 
appointments and distance to a vascular laboratory to be 
barriers to the receipt of TCD screening. Data from a 
recent study showed 72% of hematologists identified 
patient adherence to appointments to be a barrier to TCD 
screening.37 The finding that distance to a vascular labo-
ratory may be a barrier is also supported by research in a 
large, managed health care plan that found living within 
30 miles of a vascular laboratory was the only indepen-
dent predictor for receipt of TCD screening.23 One 
option to address this particular barrier to TCD screen-
ing could include offering TCD screening onsite at 
hematology clinics, as this eliminates travel to a vascu-
lar laboratory and has been shown to increase screening 
rates.30 Although both this study and ours indicated that 
physicians perceive patient-oriented issues to be the 
main barriers to receipt of TCD screening, lack of 
knowledge, and self-efficacy are perceived by caregiv-
ers as greater barriers to screening than practical issues 
such as transportation and appointment adherence.38 
The disagreement between patient and provider percep-
tions of barriers to TCD screening indicates that further 
study is necessary among both patient guardians and 
providers to identify which external factors influence 
screening rates in order to develop interventions that 
focus on the correct targets.
Some limitations of this work warrant discussion. 
The main limitation for this study is the 44% response 
rate among physicians; however, this response rate is in 
line with other physician survey response rates.39-41 
Nonresponse rates among deliverable surveys were 
similar across specialties, with 58% of PCPs, 58% of 
pediatric neurologists, and 54% of pediatric hematolo-
gists not returning deliverable surveys. The AMA 
Masterfile as a source to identify all pediatric hematolo-
gists and neurologists in the United States may have 
been incomplete and not included all specialists. As the 
survey was focused on self-report, bias may exist on 
multiple aspects of the survey, such as awareness and 
attitudes regarding screening practices. Use of PCPs 
only in the state of Michigan may limit the generaliz-
ability. Also, we did not investigate physician initiation 
of blood transfusion for patients regardless of TCD 
screening. It is possible that some doctors begin stroke 
prevention efforts without prior use of TCD results, 
although this would not be consistent with current 
guideline recommendations. Given the results of our 
survey, we were unable to determine if the existence of 
multiple guidelines, lack of physician adherence to 
guidelines, or other factors are contributing to the low 
screening rates; however, we were able to identify fac-
tors that may affect adherence for future intervention 
targets.
Conclusion
Factors such as awareness, attitudes, and knowledge of 
specific guidelines may influence physician adherence 
to TCD screening recommendations. Additional research 
regarding these barriers is necessary to understand their 
role in physician recommendation of TCD screening, 
specifically in the areas of physicians’ lack of self-effi-
cacy and knowledge of recommendations as we found 
these to be low across all specialties. This additional 
research could assist in the development of targeted 
interventions to increase TCD screening among children 
with SCD. As significant differences were found among 
specialties, specialty-specific education may be impor-
tant to improve TCD screening rates; however, substan-
tial room for improvement exists across all specialties. 
Targets for increasing TCD screening among children 
with SCD must continue to be identified in order to pre-
vent the devastating consequences of stroke in this high-
risk population.
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